A Study to Evaluate the Cue COVID Rapid Test
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 20-004999
About this study
The purpose of this study is to to evaluate the analytical performance of the Cue Health rapid (25 minute) molecular test for SARS-CoV-2 RNA using the proprietary nasal sample wand, disposable cartridge, and reader being developed by Cue Health Inc.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Adult patients, 18 years or older.
- Current order for SARS-CoV-2 testing to be collected at one of two participating collection sites in SW or SE MN.
- Provide verbal consent for an additional nasal swab collection (15 seconds each nostril) for research use only.
- Children (patients under age 18).
- Patients who do not give verbal consent for collection of additional nasal swab specimen.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Bradley Karon, M.D., Ph.D.
Closed for enrollment
Publications are currently not available